5 completed, 3 unknown, 2 terminated, 1 active not recruiting. 12 Phase 1, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 5, Unknown 3, Terminated 2, Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 8 | Completed 2, Terminated 2, Unknown 2, Active not recruiting 1, Withdrawn 1 |
Follow Diabetic Foot Ulcers: new trials by email Literature Review of Diabetic Foot Ulcers trials Research Report on Diabetic Foot Ulcers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers Omeza collagen matrix, Omeza lidocaine lavage, Omeza skin protectant - Diabetic Foot Ulcers | Phase 1 | Completed | Omeza, LLC | 25 | 2022-09-01 | 2024-06-21 |
| Wound Healing Endpoint and Recurrence Epiceram Skin Barrier Function, Vaseline Petroleum Jelly - Chronic Wound, Burn Wound | Phase 1 / Phase 2 | Active not recruiting | Sashwati Roy | 100 | 2019-01-08 | 2025-09-26 |
| Safety and Exploratory Efficacy Study of Collagen Membrane With Mesenchymal Stem Cells in the Treatment of Skin Defects Medical Collagen Membrane with MSC, Medical Collagen Membrane - Wounds, Diabetic Foot Ulcers | Phase 1 / Phase 2 | Unknown | South China Research Center for Stem Cell and Regenerative Medicine | 30 | 2016-05-01 | 2016-02-03 |
| Safety and Efficacy of Low Intensity Shockwave Therapy in Treating Diabetic Foot Ulcers Extracorporeal Shockwave Therapy and debridement, debridement and cleaning - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Unknown | Hadassah Medical Organization | 30 | 2016-04-01 | 2016-02-25 |
| Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers Granexin® gel - Diabetic Foot Ulcers | Phase 1 | Completed | Xequel Bio, Inc. | 16 | 2015-09-01 | 2018-08-01 |
| Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients Selinexor, Standard-of-Care, Vehicle Gel - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Withdrawn | Karyopharm Therapeutics Inc | 2015-01-01 | 2023-01-20 | |
| Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers Gentamicin Topical Gel, Ciprofloxacin, Doxycycline - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Terminated | Royer Biomedical, Inc. | 9 | 2014-01-01 | 2015-05-14 |
| Safety Study of Topical Human FGF-1 for Wound Healing FGF-1 141 - Diabetic Foot Ulcers | Phase 1 | Unknown | Phage Pharmaceuticals, Inc. | 8 | 2012-11-01 | 2012-03-12 |
| Utilization of Platelet Gel for Treatment of Diabetic Foot Ulcers Platelet Gel, Placebo - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Completed | Royan Institute | 30 | 2012-01-01 | 2015-12-04 |
| Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer Biochaperone PDGF-BB Low dose, Biochaperone PDGF-BB High dose, Regranex - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Completed | Virchow Group | 192 | 2010-06-01 | 2014-12-15 |
| Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers ATG002 (study drug) - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Terminated | CoMentis | 48 | 2006-10-01 | 2007-08-09 |
| Gene Therapy to Improve Wound Healing in Patients With Diabetes GAM501 - Wounds and Injuries, Diabetes | Phase 1 | Completed | Tissue Repair Company | 21 | 2002-08-01 | 2007-11-20 |
Diabetic Foot (12) · Diabetes Mellitus (4) · Wounds and Injuries (4) · Foot Ulcer (3) · Burns (2) · Adenoviridae Infections (1) · Bronchiolitis Obliterans Syndrome (1) · Infections (1) · Pressure Ulcer (1) · Ulcer (1)
Cardiovascular Diseases (12) · Diabetes Complications (12) · Diabetic Angiopathies (12) · Diabetic Neuropathies (12) · Endocrine System Diseases (12) · Leg Ulcer (12) · Skin Diseases (12) · Skin Ulcer (12) · Skin and Connective Tissue Diseases (12) · Vascular Diseases (12) · Foot Ulcer (9) · Diabetes Mellitus (8) · Glucose Metabolism Disorders (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4)
Becaplermin (1) · Ciprofloxacin (1) · Debridement (1) · Doxycycline (1) · Drug Evaluation (1) · Extracorporeal Shockwave Therapy (1) · Petroleum (1) · Standard of Care (1) · selinexor (1)
CoMentis (1) · Hadassah Medical Organization (1) · Karyopharm Therapeutics Inc (1) · Omeza, LLC (1) · Phage Pharmaceuticals, Inc. (1) · Royan Institute (1) · Royer Biomedical, Inc. (1) · Sashwati Roy (1) · South China Research Center for Stem Cell and Regenerative Medicine (1) · Tissue Repair Company (1) · Virchow Group (1) · Xequel Bio, Inc. (1)
United States (7) · India (1) · Iran (1) · New Zealand (1)
Alireza Goodarzi, MSc (1) · Barbara Sosnowski, PhD (1) · Behnam Molavi, MD (1) · Hamid Gourabi, PhD (1) · Henry Hsu, MD (1) · Nasser Aghdami, MD,PhD (1) · Richard Simman, MD (1) · Sashwati Roy, PhD (1) · Seyedeh Esmat Hosseini, Bs (1) · Shawn Searle, MD (1) · T C Raghuram, MD, Phd (1)
R44AR046154 (1)